On October 6, 2014, the United States Supreme Court declined to accept an appeal involving violations of the Foreign Corrupt Practices Act (“FCPA”)—the U.S. statute that criminalizes the bribing of foreign officials. The...more
10/22/2014
/ Appeals ,
Bribery ,
China ,
Criminal Prosecution ,
Foreign Corrupt Practices Act (FCPA) ,
GlaxoSmithKline ,
Hospitals ,
Instrumentality ,
Law Enforcement ,
Pharmaceutical Industry ,
Physicians ,
SCOTUS ,
Strategic Enforcement Plan ,
Teleco ,
UK ,
US v Esquenazi